Portal:CPTAC/FeaturedPathways
From WikiPathways
(Difference between revisions)
(typo) |
(typo) |
||
Line 15: | Line 15: | ||
|width=100px|{{#pwImage:Pathway:WP4155|250px||Endometrial cancer}} | |width=100px|{{#pwImage:Pathway:WP4155|250px||Endometrial cancer}} | ||
|width=100px|{{#pwImage:Pathway:WP4204|250px||Tumor suppressor activity of SMARCB1}} | |width=100px|{{#pwImage:Pathway:WP4204|250px||Tumor suppressor activity of SMARCB1}} | ||
- | |width=100px|{{#pwImage:Pathway:WP4205|250px|| | + | |width=100px|{{#pwImage:Pathway:WP4205|250px||MET in type 1 Papillary renal Cell Carcinoma}} |
|- | |- | ||
|width=100px|{{#pwImage:Pathway:WP4206|250px||Hereditary Leiomyomatosis and Renal Cell Carcinoma Pathway}} | |width=100px|{{#pwImage:Pathway:WP4206|250px||Hereditary Leiomyomatosis and Renal Cell Carcinoma Pathway}} |
Revision as of 21:12, 25 May 2018
Image does not exist |
Image does not exist Zhang, et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |